title: Reply to S. Alanee et al.
authors: University of Rochester Medical Center, Rochester, NY.
authors: Chunkit
authors: C
authors: Fung
authors: Norwegian Radium Hospital, Oslo, Norway.
authors: Sophie D
authors: SD
authors: Fossa
authors: University of Rochester Medical Center, Rochester, NY.
authors: Michael T
authors: MT
authors: Milano
authors: University of Rochester Medical Center, Rochester, NY.
authors: Deepak M
authors: DM
authors: Sahasrabudhe
authors: University of Rochester Medical Center, Rochester, NY.
authors: Derick R
authors: DR
authors: Peterson
authors: Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, IN lbtravis@iu.edu.
authors: Lois B
authors: LB
authors: Travis
mesh_terms: D000970:Antineoplastic Agents / Q000009:adverse effects*; D002318:Cardiovascular Diseases / Q000401:mortality*; D006801:Humans; D008297:Male; D009373:Neoplasms, Germ Cell and Embryonal / Q000628:therapy*; D009919:Orchiectomy / Q000009:adverse effects*; D013736:Testicular Neoplasms / Q000628:therapy*
chemical_list: D000970:Antineoplastic Agents